Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Vascular Neurology
How do you approach evaluating hemorrhage risk of restarting anticoagulation in patient with ischemic stroke and infective endocarditis without access to DSA?
Related Questions
How do you manage Moya-Moya disease medically for patients that are unable to receive EC-IC bypass?
When do you consider attributing isolated psychosis to an acute ischemic stroke?
When do you consider thrombectomy for patients with LVO and carotid dissection?
How do you manage high-risk MDS IB2 patients on HMA and venetoclax who develop an acute stroke requiring antiplatelet therapy?
How do structural and functional findings on echocardiogram influence your decision to anticogulate ESUS cases?
Can you clinically distinguish TIAs from transient focal neurologic episodes (TFNEs) of cerebral amyloid?
What is the optimal BP target for patients with diabetes and hypertension to reduce their risk of MI/stroke?
When do you offer propranolol for treatment of familial cerebral cavernous malformations?
Do you make any dose adjustments for patients with ESKD who are on apixaban and do not otherwise meet criteria for reduced dosing?
How do you treat a mild basilar artery occlusion stroke?
